Questionnaires in Describing the Natural History of Reproductive and Sexual Health in Patients with Stage 0-III Breast Cancer or Aggressive Lymphoma

Inclusion Criteria

• COHORT OF PREMENOPAUSAL: Women, 18 years of age and older
• COHORT OF PREMENOPAUSAL: Premenopausal at time of diagnosis who have either been pregnant or had at least one menstrual period in the last 12 months * Note: premenopausal women at time of diagnosis who have not been pregnant or have not had at least one menstrual period in the last 12 months are able to participate only if they have had an intrauterine device (IUD) in place within the last 12 months
• COHORT OF PREMENOPAUSAL: Women with newly diagnosed breast cancer (stage 0-III) who are within 1 month of starting systemic treatment or women with any aggressive lymphoma being treated with first line therapy with curative intent
• COHORT OF PREMENOPAUSAL: Breast cancer patients with any receptor type
• COHORT OF PREMENOPAUSAL: English speaking
• COHORT OF PREMENOPAUSAL: Able to participate in the informed consent process
• TAMOXIFEN ONLY SUBSET OF COHORT OF PREMENOPAUSAL: Women, 18 years of age and older
• TAMOXIFEN ONLY SUBSET OF COHORT OF PREMENOPAUSAL: Premenopausal at time of diagnosis who have either been pregnant or had at least one menstrual period in the last 12 months * Note: premenopausal women at time of diagnosis who have not been pregnant or have not had at least one menstrual period in the last 12 months are able to participate only if they have had an intrauterine device (IUD) in place within the last 12 months
• TAMOXIFEN ONLY SUBSET OF COHORT OF PREMENOPAUSAL: Women with newly diagnosed breast cancer (stage 0-III) who have not yet started treatment and are planning to start tamoxifen as their only form of systemic treatment within one month
• TAMOXIFEN ONLY SUBSET OF COHORT OF PREMENOPAUSAL: Breast cancer patients with any receptor type
• TAMOXIFEN ONLY SUBSET OF COHORT OF PREMENOPAUSAL: English speaking
• TAMOXIFEN ONLY SUBSET OF COHORT OF PREMENOPAUSAL: Able to participate in the informed consent process
• POSTMENOPAUSAL: Women, 18 years of age and older
• POSTMENOPAUSAL: Postmenopausal at time of diagnosis who have been without a period for >= 2 years
• POSTMENOPAUSAL: Women with newly diagnosed breast cancer (stage 0-III) who are within 1 month of starting systemic treatment or women with any aggressive lymphoma being treated with first line therapy with curative intent
• POSTMENOPAUSAL: Breast cancer patients with any receptor type
• POSTMENOPAUSAL: English speaking
• POSTMENOPAUSAL: Able to participate in the informed consent process

Exclusion Criteria

• Active secondary cancer requiring cytotoxic chemotherapy
• Prior systemic treatment for a malignancy